Ruth Boxall

Ruth Boxall

Auto-generated profile, based on publicly available information

Ruth Boxall

Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, University of Oxford , Old Road Campus, Roosevelt Drive, Oxford OX3 7LF , UK Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford , Old Road Campus, Roosevelt Drive, Oxford OX3 7LF , UK

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in JACC
Verified
Journal Article
Open access
MHMichael V. Holmes
Michael V. Holmes
IMIona Y. Millwood
Iona Y. Millwood
CKChristiana Kartsonaki
Christiana Kartsonaki
MHMichael R. Hill
Michael R. Hill
DBDerrick A. Bennett
Derrick A. Bennett
ZCZhengming Chen
Zhengming Chen
Blood lipids are established risk factors for myocardial infarction (MI), but uncertainty persists about the relevance of lipids, lipoprotein particles, and circulating metabolites for MI and stroke subtypes. This study sought to investigate the associations of plasma metabolic markers with risks of incident MI, ischemic stroke (IS), and intracerebral hemorrhage (ICH). In a nested case-control study (912 MI, 1,146 IS, and 1,138 ICH cases, and 1,466 common control subjects) 30 to 79 years of age in China Kadoorie Biobank, nuclear magnetic resonance spectroscopy measured 225 metabolic markers in baseline plasma samples. Logistic regression was used to estimate adjusted odds ratios (ORs) for a 1-SD higher metabolic marker. Very low-, intermediate-, and low-density lipoprotein particles were positively associated with MI and IS. High-density lipoprotein (HDL) particles were inversely associated with MI apart from small HDL. In contrast, no lipoprotein particles were associated with ICH. Cholesterol in large HDL was inversely associated with MI and IS (OR: 0.79 and 0.88, respectively), whereas cholesterol in small HDL was not (OR: 0.99 and 1.06, respectively). Triglycerides within all lipoproteins, including most HDL particles, were positively associated with MI, with a similar pattern for IS. Glycoprotein acetyls, ketone bodies, glucose, and docosahexaenoic acid were associated with all 3 diseases. The 225 metabolic markers showed concordant associations between MI and IS, but not with ICH. Lipoproteins and lipids showed similar associations with MI and IS, but not with ICH. Within HDL particles, cholesterol concentrations were inversely associated, whereas triglyceride concentrations were positively associated with MI. Glycoprotein acetyls and several non-lipid-related metabolites associated with all 3 diseases.

3 February 2015 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
GDG Davies
G Davies
NAN Armstrong
N Armstrong
JBJ C Bis
J C Bis
JBJ Bressler
J Bressler
VCV Chouraki
V Chouraki
IDIan Deary
Ian Deary
General cognitive function is substantially heritable across the human life course from adolescence to old age. We investigated the genetic contribution to variation in this important, health- and well-being-related trait in middle-aged and older adults. We conducted a meta-analysis of genome-wide association studies of 31 cohorts (N=53 949) in which the participants had undertaken multiple, diverse cognitive tests. A general cognitive function phenotype was tested for, and created in each cohort by principal component analysis. We report 13 genome-wide significant single-nucleotide polymorphism (SNP) associations in three genomic regions, 6q16.1, 14q12 and 19q13.32 (best SNP and closest gene, respectively: rs10457441, P=3.93 × 10−9, MIR2113; rs17522122, P=2.55 × 10−8, AKAP6; rs10119, P=5.67 × 10−9, APOE/TOMM40). We report one gene-based significant association with the HMGN1 gene located on chromosome 21 (P=1 × 10−6). These genes have previously been associated with neuropsychiatric phenotypes. Meta-analysis results are consistent with a polygenic model of inheritance. To estimate SNP-based heritability, the genome-wide complex trait analysis procedure was applied to two large cohorts, the Atherosclerosis Risk in Communities Study (N=6617) and the Health and Retirement Study (N=5976). The proportion of phenotypic variation accounted for by all genotyped common SNPs was 29% (s.e.=5%) and 28% (s.e.=7%), respectively. Using polygenic prediction analysis, ~1.2% of the variance in general cognitive function was predicted in the Generation Scotland cohort (N=5487; P=1.5 × 10−17). In hypothesis-driven tests, there was significant association between general cognitive function and four genes previously associated with Alzheimer’s disease: TOMM40, APOE, ABCG1 and MEF2C.

1 January 2018 in JAMA Cardiology
Verified
Journal Article
Open access
PDF file
IMIona Millwood
Iona Millwood
DBDerrick A. Bennett
Derrick A. Bennett
MHMichael V. Holmes
Michael V. Holmes
RBRuth Boxall
Ruth Boxall
YGYu Guo
Yu Guo
ZCZhengming Chen
Zhengming Chen
Observational epidemiologic studies have reported that low plasma concentrations of high-density lipoprotein (HDL) cholesterol are an independent risk factor for occlusive cardiovascular disease (CVD), including coronary heart disease (CHD) and ischemic stroke.1,2 Given these associations, therapeutic strategies to reduce CVD risk by increasing HDL cholesterol concentrations have attracted considerable interest. One such approach is through pharmacologic inhibition of cholesterol ester transfer protein (CETP), which transfers esterified cholesterol from HDL to apolipoprotein B–containing lipoproteins, including very low-density lipoprotein (VLDL), in exchange for triglycerides.3 The first CETP inhibitor assessed in phase 3 trials, torcetrapib, was associated with increased CVD risk, probably owing to off-target effects.4,5 Subsequent trials of dalcetrapib (which had only modest effects on HDL cholesterol) or evacetrapib (which increased HDL cholesterol levels substantially and lowered LDL cholesterol levels) were stopped early for futility after 2 to 3 years of treatment in high-risk individuals.6,7 A trial of the potent CETP inhibitor anacetrapib (which doubled HDL cholesterol levels and lowered non-HDL cholesterol levels by about one-fifth) that involved approximately 30 000 high-risk individuals treated for 4 years recently reported a benefit for risk of major coronary events consistent with the effects of lowering non-HDL cholesterol levels.8

1 April 2015 in Biological Psychiatry
Verified
Journal Article
Closed access
SDStéphanie Debette
Stéphanie Debette
CVCarla A. Ibrahim Verbaas
Carla A. Ibrahim Verbaas
JBJan Bressler
Jan Bressler
MSMaaike Schuur
Maaike Schuur
ASAlbert Smith
Albert Smith
TMThomas H. Mosley
Thomas H. Mosley

1 March 2015 in Journal of Psychiatric Research
Verified
Journal Article
Open access
RWRosie May Walker
Rosie May Walker
JRJoanna Rybka
Joanna Rybka
SASusan Maguire Anderson
Susan Maguire Anderson
HTHelen Scott Torrance
Helen Scott Torrance
RBRuth Boxall
Ruth Boxall
KEKathryn Louise Evans
Kathryn Louise Evans
Bipolar disorder (BD) is a highly heritable psychiatric disorder characterised by recurrent episodes of mania and depression. Many studies have reported altered gene expression in BD, some of which may be attributable to the dysregulated expression of miRNAs. Studies carried out to date have largely studied medicated patients, so it is possible that observed changes in miRNA expression might be a consequence of clinical illness or of its treatment. We sought to establish whether altered miRNA expression might play a causative role in the development of BD by studying young, unmedicated relatives of individuals with BD, who are at a higher genetic risk of developing BD themselves (high-risk individuals). The expression of 20 miRNAs previously implicated in either BD or schizophrenia was measured by qRT-PCR in whole-blood samples from 34 high-risk and 46 control individuals. Three miRNAs, miR-15b, miR-132 and miR-652 were up-regulated in the high-risk individuals, consistent with previous reports of increased expression of these miRNAs in patients with schizophrenia. Our findings suggest that the altered expression of these miRNAs might represent a mechanism of genetic susceptibility for BD. Moreover, our observation of altered miRNA expression in the blood prior to the onset of illness provides hope that one day blood-based tests may aid in the risk-stratification and treatment of BD.

26 January 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RBRuth Boxall
Ruth Boxall
DPDavid J. Porteous
David J. Porteous
PTPippa A. Thomson
Pippa A. Thomson
We re-annotated the interacting partners of the neuronal scaffold protein DISC1 using a knowledge-based approach that incorporated recent protein interaction data and published literature to. This revealed two highly connected networks. These networks feature cellular function and maintenance, and cell signaling. Of potentially greatest interest was the novel finding of a high degree of connectivity between the DISC1 scaffold protein, linked to psychiatric illness, and huntingtin, the protein which is mutated in Huntington's disease. The potential link between DISC1, huntingtin and their interacting partners may open new areas of research into the effects of pathway dysregulation in severe neurological disorders.